Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity
Recruiting now · Phase 1 · Has a placebo group
Conditions studied: Overweight or Obesity
In brief
This study will test a study drug called REGN20934 to see how safe and well tolerated this drug is, as well as how the drug is processed in the body for participants with overweight or obesity. The study is looking at: * What side effects REGN20934 might cause * How much REGN20934 is in the blood at different times * If the body makes antibodies to REGN20934
Key facts
- Study ID
- NCT07594093
- Run by
- Regeneron Pharmaceuticals
- People needed
- 90
- Starts
- 2026-06-29
- Expected to finish
- 2027-02-22
- Last updated by the study team
- 2026-07-07
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
Where it is running
- California Clinical Trials Medical Group — Glendale, California, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.